Cargando…

Clinical Significance of Factor XIII Activity and Monocyte-Derived Microparticles in Cancer Patients

BACKGROUND: The aim was to evaluate factor XIII activity (FXIIIa) and monocyte-derived microparticles (MDMPs) in cancer patients. METHODS: In total, 138 cancer patients (31 malignant lymphomas, 39 multiple myelomas, and 68 lung cancers) were analyzed. We measured various biomarkers including FXIIIa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sawai, Yusuke, Yamanaka, Yuta, Nomura, Shosaku
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131992/ https://www.ncbi.nlm.nih.gov/pubmed/32280233 http://dx.doi.org/10.2147/VHRM.S240500

Ejemplares similares

Platelet-Derived Microparticles are an Important Biomarker in Patients with Cancer-Associated Thrombosis
por: Yamanaka, Yuta, et al.
Publicado: (2019)

Clinical significance of procoagulant microparticles
por: Nomura, Shosaku, et al.
Publicado: (2015)

Effects of febuxostat on platelet-derived microparticles and adiponectin in patients with hyperuricema
por: Nishizawa, Tohru, et al.
Publicado: (2015)

Activation mechanism dependent surface exposure of cellular factor XIII on activated platelets and platelet microparticles
por: Somodi, Laura, et al.
Publicado: (2022)

Microparticles as Biomarkers of Blood Coagulation in Cancer
por: Nomura, Shosaku, et al.
Publicado: (2015)

Assessment of soluble cytotoxic T lymphocyte-associated antigen-4, transforming growth factor β(1), and platelet-derived microparticles during dasatinib therapy for patients with chronic myelogenous leukemia
por: Nomura, Shosaku, et al.
Publicado: (2018)

Effects of miglitol in platelet-derived microparticle, adiponectin, and selectin level in patients with type 2 diabetes mellitus
por: Nomura, Shosaku, et al.
Publicado: (2011)

Monocytes Expose Factor XIII-A and Stabilize Thrombi against Fibrinolytic Degradation
por: Alshehri, Fahad S. M., et al.
Publicado: (2021)

Potential Involvement of Platelet-Derived Microparticles and Microparticles Forming Immune Complexes during Monocyte Activation in Patients with Systemic Lupus Erythematosus
por: Burbano, Catalina, et al.
Publicado: (2018)

Treatment with Recombinant Factor XIII (Tretten) in a Pregnant Woman with Factor XIII Deficiency
por: Abdel-Samad, Nizar
Publicado: (2017)

Macrophages-derived Factor XIII links coagulation to inflammation in COPD
por: Bazzan, Erica, et al.
Publicado: (2023)

Advances of Coagulation Factor XIII
por: Shi, Da-Yu, et al.
Publicado: (2017)

Role of microparticles derived from monocytes, endothelial cells and platelets in the exacerbation of COPD
por: Tőkés-Füzesi, Margit, et al.
Publicado: (2018)

Endothelial Cell‐, Platelet‐, and Monocyte/Macrophage‐Derived Microparticles are Elevated in Psoriasis Beyond Cardiometabolic Risk Factors
por: Takeshita, Junko, et al.
Publicado: (2014)

Platelet-, monocyte-derived and tissue factor-carrying circulating microparticles are related to acute myocardial infarction severity
por: Chiva-Blanch, Gemma, et al.
Publicado: (2017)

Plasma Factor XIII Activity in Patients with Disseminated Intravascular Coagulation
por: Song, Jae Woo, et al.
Publicado: (2006)

Clinical Validation of an Automated Fluorogenic Factor XIII Activity Assay Based on Isopeptidase Activity
por: Leitner, Martina, et al.
Publicado: (2021)

Association of High Mobility Group Box-Protein 1 and Platelet Microparticles in Patients After Hematopoietic Stem Cell Transplantation
por: Nomura, Shosaku, et al.
Publicado: (2023)

Refractory Duodenal Bleeding Ulcers Successfully Treated with Factor XIII Transfusion
por: Yamada, Yusuke, et al.
Publicado: (2021)

León XIII
por: Hayward, Fernand, b. 1888
Publicado: (1952)

Inhibition of Fibrinolysis by Coagulation Factor XIII
por: Rijken, Dingeman C., et al.
Publicado: (2017)

The Release of Monocyte-Derived Tissue Factor-Positive Microparticles Contributes to a Hypercoagulable State in Idiopathic Membranous Nephropathy
por: Wang, Gui Hua, et al.
Publicado: (2019)

Safety and effectiveness of recombinant factor XIII‐A(2) in congenital factor XIII deficiency: Real‐world evidence
por: Poulsen, Lone Hvitfeldt, et al.
Publicado: (2022)

Impaired Activity of Blood Coagulant Factor XIII in Patients with Necrotizing Enterocolitis
por: Tao, Guo-Zhong, et al.
Publicado: (2015)

Measuring Factor XIII Inhibitors in Patients with Factor XIII Deficiency: A Case Report and Systematic Review of Current Practices in Japan
por: Amano, Shiho, et al.
Publicado: (2022)

Efficacy of gefapixant, a P2X(3) antagonist, for lung cancer-related cough: a case report
por: Ishiura, Yoshihisa, et al.
Publicado: (2023)

Effect of Factor XIII on Endothelial Barrier Function
por: Noll, Thomas, et al.
Publicado: (1999)

Coagulation Factor XIII in Cerebral Venous Thrombosis
por: Li, Bojun, et al.
Publicado: (2019)

Factor XIII Deficiency Associated With Noonan Syndrome
por: Kharel, Zeni, et al.
Publicado: (2021)

XIII Sitges Conference
por: Brey, J J, et al.
Publicado: (1995)

Clinical Studies. XIII.—Etiology of Disseminated Sclerosis
por: Bramwell, Byrom
Publicado: (1917)

The significance of measuring monocyte tissue factor activity in patients with breast and colorectal cancer
por: Lwaleed, B A, et al.
Publicado: (1999)

Clinical significance of monocyte heterogeneity
por: Stansfield, Brian K, et al.
Publicado: (2015)

Monocytic microparticles promote atherogenesis by modulating inflammatory cells in mice
por: Hoyer, Friedrich Felix, et al.
Publicado: (2012)

Alfonso XIII : un rey, una época
por: Vila-San-Juan, José Luis, 1927-

A Rare Case of Factor XIII Deficiency in the Setting of Cancer Immunotherapy
por: Farzam, Khashayar
Publicado: (2021)

Novel deep intronic mutation in the coagulation factor XIII a chain gene leading to unexpected RNA splicing in a patient with factor XIII deficiency
por: Deng, Jun, et al.
Publicado: (2020)

Factor XIII-A: An Indispensable “Factor” in Haemostasis and Wound Healing
por: Alshehri, Fahad S. M., et al.
Publicado: (2021)

Tocilizumab Effects on Coagulation Factor XIII in Patients with Rheumatoid Arthritis
por: Gualtierotti, Roberta, et al.
Publicado: (2019)

Current understanding in diagnosis and management of factor XIII deficiency
por: Naderi, M, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_94sf7n19o5ii1vktj86f4il99a